Athena Pharmaceutiques Oral Dispersible Tablets

Athena Pharmaceutiques Oral Dispersible Tablets

X

Company profile for Nomisma Healthcare

Nomisma Healthcare

NOMISMA HEALTHCARE

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

DEVELOPMENTS

No Content

EXCIPIENTS

5 Listed Products

5 Listed Products

EXCIPIENTS BY INGREDIENTS

2 Poly L Lactide, 1 Poly DL Lactide co Glycolide , 1 Polyethylene Glycol Excipients, 1 Polyethylene Glycol Excipient, 1 Poly-DL-Lactic-co-Glycolic Acid, 1 Poly DL Lactide

2 Poly L Lactide
- Injectable / Parenteral
- Tablet
1 Poly DL Lactide co Glycolide
- Injectable / Parenteral
- Tablet
1 Polyethylene Glycol Excipients
- Tablet
1 Polyethylene Glycol Excipient
- Tablet
1 Poly-DL-Lactic-co-Glycolic Acid
- Tablet
1 Poly DL Lactide
- Injectable / Parenteral
- Tablet

EXCIPIENTS BY APPLICATIONS

Controlled & Modified Release, Parenteral

List of Excipients

Contact Supplier

Contact Supplier

Full View Screen

Full Screen View

Nomisma Healthcare

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

PLLA

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications: PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Ingredient(s): Poly L Lactide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

CPHI India 2023

Attending

envelop Contact Supplier

Nomisma Healthcare

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

PLLA-PEG

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications: PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide; Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

CPHI India 2023

Attending

envelop Contact Supplier

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

laboratorium-ofichem-b-v-m-2023-03-20

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

CPHI India 2023

Attending

envelop Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search